Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$62.0 - $79.01 $1.62 Million - $2.07 Million
26,200 New
26,200 $1.91 Million
Q1 2023

May 15, 2023

BUY
$16.26 - $21.73 $43,902 - $58,671
2,700 New
2,700 $46,000
Q3 2019

Nov 14, 2019

SELL
$15.49 - $25.78 $72,803 - $121,166
-4,700 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$23.0 - $32.19 $108,100 - $151,293
4,700 New
4,700 $120,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $8.98B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.